2018 Medical science Side effects 
European Pharmaceutical Review
MAY 23, 2024
About the interviewee Imran Khan, MD, PhD is Vice President Medical Affairs, Hematology at Johnson & Johnson Innovative Medicine. Most recently, Imran has served as Medical Science Liaison (MSL) Head, Oncology U.S. Medical Affairs. CAR T-cell Therapy and its side effects [Internet]. Cancer.gov.
European Pharmaceutical Review
AUGUST 15, 2024
BTKis, oral drugs given as continuous monotherapy, have revolutionised the treatment of CLL, with the first generation BTKi ibrutinib receiving European Medicines Agency (EMA) approval in 2014; however, side-effects (such as cardiovascular toxicities 2 ) have limited its suitability. 2018; 378(12):1107–20. 2022; 36(4):1171–5.
Expert insights. Personalized for you.
110 
Let's personalize your content